SIGN IN YOUR ACCOUNT TO HAVE ACCESS TO DIFFERENT FEATURES

FORGOT YOUR PASSWORD?

FORGOT YOUR DETAILS?

AAH, WAIT, I REMEMBER NOW!

MITUMITU

info@mitu.or.tz | +255 28 2500019 | Staff Mail
  • LOGIN
  • WHO WE ARE
    • History & Background
    • Mission & Values
    • Strategic Plan
    • Organization Structure
    • Our Team
  • WHERE WE ARE
    • Mwanza Medical Research Centre
    • Mwanza City
  • WHAT WE DO
    • Research Programme
    • Capacity Building
    • Research Facilities
  • PUBLICATIONS
  • NEWS & EVENTS
    • News & Events
    • Career
  • CONTACT US
Wednesday, 14 October 2020 / Published in 2020, Publication

Disclosure of PrEP use by young women in South Africa and Tanzania: qualitative findings from ademonstration project

Disclosure of PrEP use by young women in South Africa and Tanzania: qualitative findings from ademonstration project.

Scorgie F, Khoza N, Baron D, Lees S, Harvey S, Ramskin L, Stangl A, Colombini M, Mashauri E, Delany-Moretlwe S; EMPOWER study team.

Cult Health Sex. 2020 Mar 4:1-16.

PMID: 32129720

DOI: 10.1080/13691058.2019.1703041

  • Tweet
  • Share 0
  • Pocket
  • LinkedIn 0
  • Email

What you can read next

The incidence of human papillomavirus in Tanzanian adolescent girls before reported sexual debut.
Epidemiology of Drug Use and HIV-related Risk Behaviors among People who Inject Drugs in Mwanza, Tanzania.
Intravaginal and menstrual practices among women working in food and recreational facilities in Mwanza, Tanzania: implications for microbicide trials.

Filter by Year

  • All Publications
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003

Recent Posts

  • Job Vacancy: Senior Finance Officer

  • MITU launches a new human papilloma virus (HPV) vaccine trial among boys in  Tanzania

  • Same habitus in new field? How mobile phone communication reproduces masculinities and gender inequality in intimate relationships in Mwanza, Tanzania.

  • Comparison of Immune Responses after One Dose of HPV Vaccine in a Dose-Reduction HPV Vaccine Trial in Adolescent Girls in Tanzania to the Costa Rica Vaccine and India HPV Vaccine Trials.

  • Immunogenicity and Safety Results Comparing Single Dose Human Papillomavirus Vaccine with Two or Three Doses in Tanzanian Girls – the DoRIS Randomised Trial.

Receive our latest news straight to your inbox

Join 220 other subscribers

CONTACT US

Contact us through the address below
Mwanza Intervention Trials Unit.

MITU, Isamilo Street,
P.O. Box11936,
Mwanza, Tanzania.

info@mitu.or.tz

+255 28 2500019

WHO WE ARE

  • History & Background
  • Mission & Values
  • Strategic Plan
  • Organization Structure
  • Our Team

WHAT WE DO

  • Research Programme
  • Capacity Building
  • Research Facilities

OUR SOCIAL

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

OUR PARTNERS

Tweets by mituorg
© 2021 MITU | All rights reserved.
TOP